Please provide your email address to receive an email when new articles are posted on . A retrospective cohort study of more than 200 patients with medically refractory focal epilepsy that examined ...
Continuous intracranial electroencephalography (cEEG) may help pinpoint optimal timing of diagnostic studies and treatment for patients with focal epilepsy, new research suggests. The findings from a ...
Having subtler symptoms, a form of epilepsy that affects only one part of the brain often goes undiagnosed long enough to cause unexpected seizures that contribute to car crashes, a new study finds.
University of California San Diego is conducting new, Phase 2/3 national epilepsy clinical research trials, called Rise, to study BHV-7000, a novel investigational therapy, in focal epilepsy.
The US Food and Drug Administration (FDA) has approved cenobamate (Xcopri, SK Life Science) for the treatment of partial-onset seizures in adult patients with epilepsy. Today's approval was based on ...
About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly to available therapies. Yet they, too, may eventually see improvement, if ...
The first seizure clinic model enabled rapid diagnosis and treatment for children with epilepsy, according to data presented ...
The Naox Link in-ear EEG platform is the first of its kind to be cleared for prescription use at home or in healthcare ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Valproate (Depakene) emerged as the best first-line choice for ...
In new study results, researchers from the University of Alabama at Birmingham found that administering the preventive epilepsy treatment vigabatrin prior to seizure onset did not improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback